125 related articles for article (PubMed ID: 33998498)
21. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Kociol RD; McNulty SE; Hernandez AF; Lee KL; Redfield MM; Tracy RP; Braunwald E; O'Connor CM; Felker GM;
Circ Heart Fail; 2013 Mar; 6(2):240-5. PubMed ID: 23250981
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors for in-hospital mortality of patients hospitalized for acutely decompensated heart failure.
Dvornik Š; Zaninović Jurjević T; Jurjević N; Lekić A; Zaputović L
Acta Clin Belg; 2018 Jun; 73(3):199-206. PubMed ID: 29207933
[TBL] [Abstract][Full Text] [Related]
23. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS
Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021
[TBL] [Abstract][Full Text] [Related]
24. Complex assessment of patients with decompensated heart failure: The clinical value of impedance cardiography and N-terminal pro-brain natriuretic peptide.
Galas A; Krzesiński P; Gielerak G; Piechota W; Uziębło-Życzkowska B; Stańczyk A; Piotrowicz K; Banak M
Heart Lung; 2019; 48(4):294-301. PubMed ID: 30391076
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of red cell distribution width and other red cell parameters in patients with chronic heart failure during two years of follow-up.
Wołowiec Ł; Rogowicz D; Banach J; Buszko K; Surowiec A; Błażejewski J; Bujak R; Sinkiewicz W
Kardiol Pol; 2016; 74(7):657-64. PubMed ID: 26779853
[TBL] [Abstract][Full Text] [Related]
26. Prognosis of decompensated heart failure: role of NT-proBNP.
Ferreira S; Almeida R; Guerrero H; Lourenço-Ferreira S; Fonseca L; Rocha R; Rocha-Gonçalves F; Ferreira A; Bettencourt P
Rev Port Cardiol; 2007 May; 26(5):535-45. PubMed ID: 17691279
[TBL] [Abstract][Full Text] [Related]
27. Assessment of clinical and hemodynamic congestion as predictors of mortality in elderly outpatients with heart failure.
Gil-Martínez P; Curbelo J; Roy-Vallejo E; Mesado-Martínez D; Ciudad-Sañudo M; Suárez-Fernández C
Rev Clin Esp (Barc); 2022; 222(7):377-384. PubMed ID: 35537991
[TBL] [Abstract][Full Text] [Related]
28. Urine N-terminal pro b-type natriuretic peptide is predictive of heart failure-related emergency department visits.
Chen JY; Lee SY; Tsai WC; Lin CY; Shieh MD; Ciou DS
ESC Heart Fail; 2020 Oct; 7(5):2672-2678. PubMed ID: 32613707
[TBL] [Abstract][Full Text] [Related]
29. Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
Ehteshami-Afshar S; Mooney L; Dewan P; Desai AS; Lang NN; Lefkowitz MP; Petrie MC; Rizkala AR; Rouleau JL; Solomon SD; Swedberg K; Shi VC; Zile MR; Packer M; McMurray JJV; Jhund PS; Hawkins NM
J Am Heart Assoc; 2021 Feb; 10(4):e019238. PubMed ID: 33522249
[TBL] [Abstract][Full Text] [Related]
30. Influence of renal dysfunction phenotype on mortality in decompensated heart failure with preserved and mid-range ejection fraction.
Casado J; Sánchez M; Garcés V; Manzano L; Cerqueiro JM; Epelde F; García-Escrivá D; Pérez-Silvestre J; Morales JL; Montero-Pérez-Barquero M;
Int J Cardiol; 2017 Sep; 243():332-339. PubMed ID: 28528982
[TBL] [Abstract][Full Text] [Related]
31. [The prognostic role of extremely high levels of the B-type natriuretic prohormone with regard to the in-hospital mortality of patients hospitalized for heart failure].
Bózsik B; Nagy E; Somlói M; Tomcsányi J
Orv Hetil; 2017 May; 158(20):779-782. PubMed ID: 28502208
[TBL] [Abstract][Full Text] [Related]
32. Modified Glasgow Prognostic Score is a novel predictor of clinical outcome in heart failure with preserved ejection fraction.
Bolat I; Biteker M
Scand Cardiovasc J; 2020 Jun; 54(3):174-178. PubMed ID: 31965867
[No Abstract] [Full Text] [Related]
33. Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure.
Hamatani Y; Iguchi M; Ueno K; Aono Y; Esato M; Tsuji H; Wada H; Hasegawa K; Ogawa H; Abe M; Morita S; Akao M
Heart; 2021 May; 107(9):705-712. PubMed ID: 33219109
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population.
Groenning BA; Raymond I; Hildebrandt PR; Nilsson JC; Baumann M; Pedersen F
Heart; 2004 Mar; 90(3):297-303. PubMed ID: 14966052
[TBL] [Abstract][Full Text] [Related]
35. Independent prognostic value of echocardiography and N-terminal pro-B-type natriuretic peptide in patients with heart failure.
Hinderliter AL; Blumenthal JA; O'Conner C; Adams KF; Dupree CS; Waugh RA; Bensimhon D; Christenson RH; Sherwood A
Am Heart J; 2008 Dec; 156(6):1191-5. PubMed ID: 19033018
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
37. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
[TBL] [Abstract][Full Text] [Related]
38. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.
Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Drouet E; Linde C; Daubert C;
Eur J Heart Fail; 2015 Jul; 17(7):680-8. PubMed ID: 26033771
[TBL] [Abstract][Full Text] [Related]
39. Predictors of Long-Term Mortality in Older Patients Hospitalized for Acutely Decompensated Heart Failure: Clinical Relevance of Natriuretic Peptides.
Passantino A; Guida P; Lagioia R; Ammirati E; Oliva F; Frigerio M; Scrutinio D
J Am Geriatr Soc; 2017 Apr; 65(4):822-826. PubMed ID: 27889914
[TBL] [Abstract][Full Text] [Related]
40. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
Januzzi JL; Sakhuja R; O'donoghue M; Baggish AL; Anwaruddin S; Chae CU; Cameron R; Krauser DG; Tung R; Camargo CA; Lloyd-Jones DM
Arch Intern Med; 2006 Feb; 166(3):315-20. PubMed ID: 16476871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
